HRP20070574T3 - Antimycobacterial pharmaceutical composition comprising an antitubercular drug - Google Patents

Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Info

Publication number: HRP20070574T3
Authority: HR; Croatia
Prior art keywords: pharmaceutical composition; antimycobacterial; antitubercular drug; antimycobacterial pharmaceutical; methyl
Prior art date: 2004-05-12

Application number

HR20070574T

Other languages

English (en)

Croatian (hr)

Inventor

Kumar Arora Sudershan

Sinha Neelima

Sinha Rakesh

Shankar Upadhyaya Ram

Original Assignee

Lupin Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2004-08-27

Publication date

2008-01-31

2004-08-27 Application filed by Lupin Limited filed Critical Lupin Limited

2008-01-31 Publication of HRP20070574T3 publication Critical patent/HRP20070574T3/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HR20070574T 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug HRP20070574T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/844,992 US7491721B2 (en)	2004-05-12	2004-05-12	Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (fr)	2004-05-12	2004-08-27	Composition pharmaceutique antimycobacterienne

Publications (1)

Publication Number	Publication Date
HRP20070574T3 true HRP20070574T3 (en)	2008-01-31

Family

ID=34960626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20070574T HRP20070574T3 (en)	2004-05-12	2004-08-27	Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Country Status (44)

Country	Link
US (1)	US7491721B2 (fr)
EP (1)	EP1750765B1 (fr)
JP (1)	JP2007537242A (fr)
KR (1)	KR100854309B1 (fr)
CN (1)	CN1956732B (fr)
AP (1)	AP1994A (fr)
AR (1)	AR048948A1 (fr)
AT (1)	ATE373488T1 (fr)
AU (1)	AU2004319259A1 (fr)
BR (1)	BRPI0418770A (fr)
CA (1)	CA2566440C (fr)
CR (1)	CR8748A (fr)
DE (1)	DE602004009113T2 (fr)
DK (1)	DK1750765T3 (fr)
DO (1)	DOP2005000085A (fr)
EA (1)	EA009694B1 (fr)
EC (1)	ECSP066965A (fr)
ES (1)	ES2294577T3 (fr)
GE (1)	GEP20094805B (fr)
HN (1)	HN2005000210A (fr)
HR (1)	HRP20070574T3 (fr)
IL (1)	IL178858A (fr)
IS (1)	IS8559A (fr)
JO (1)	JO2471B1 (fr)
MA (1)	MA28603B1 (fr)
MX (1)	MXPA06012984A (fr)
MY (1)	MY139187A (fr)
NI (1)	NI200600270A (fr)
NO (1)	NO20065725L (fr)
NZ (1)	NZ550892A (fr)
PA (1)	PA8633001A1 (fr)
PE (1)	PE20060353A1 (fr)
PL (1)	PL1750765T3 (fr)
PT (1)	PT1750765E (fr)
RS (1)	RS20060624A (fr)
SA (1)	SA05260130B1 (fr)
SI (1)	SI1750765T1 (fr)
SM (1)	SM200500011B (fr)
SV (1)	SV2006002109A (fr)
TN (1)	TNSN06349A1 (fr)
UA (1)	UA82782C2 (fr)
UY (1)	UY28893A1 (fr)
WO (1)	WO2005107809A2 (fr)
ZA (1)	ZA200608843B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090118509A1 (en) *	2005-04-11	2009-05-07	Lupin Limited	Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) *	2008-10-02	2013-11-13	公益財団法人微生物化学研究会	抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) *	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
AU2010292148A1 (en) *	2009-09-11	2012-04-12	Vertex Pharmaceuticals Incorporated	Compositions of N-benzyl-3-(4-chlorophenyl)-2- [methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-N- [3-(4-pyridyl)-1-[2-[4-pyridyl)ethy]propyl]propanamide and uses thereof
HUP1000033A2 (en) *	2010-01-21	2011-07-28	Uratim Kft	Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) *	2021-10-20	2022-11-03	순천향대학교 산학협력단	신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
WO2023217239A1 (fr) *	2022-05-12	2023-11-16	广州嘉越医药科技有限公司	Composition pharmaceutique et utilisation associée
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same
CN118743705B (zh) *	2024-08-12	2024-11-15	深圳大学	药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5227383A (en) *	1991-06-14	1993-07-13	The University Of Mississippi	Compounds and compositions useful as antifungal and antimycobacterial agents
BR0215873A (pt) *	2002-09-20	2005-07-12	Lupin Ltd	Composto, composição farmacêutica, método de inibição de desenvolvimento de células microbianas, método para o tratamento de condições microbianas em mamìferos e processo para a preparação de um composto

2004
- 2004-05-12 US US10/844,992 patent/US7491721B2/en not_active Expired - Fee Related
- 2004-08-27 NZ NZ550892A patent/NZ550892A/en unknown
- 2004-08-27 CA CA002566440A patent/CA2566440C/fr not_active Expired - Fee Related
- 2004-08-27 EA EA200601952A patent/EA009694B1/ru not_active IP Right Cessation
- 2004-08-27 AU AU2004319259A patent/AU2004319259A1/en not_active Abandoned
- 2004-08-27 BR BRPI0418770-9A patent/BRPI0418770A/pt not_active IP Right Cessation
- 2004-08-27 RS YUP-2006/0624A patent/RS20060624A/sr unknown
- 2004-08-27 PT PT04816650T patent/PT1750765E/pt unknown
- 2004-08-27 CN CN2004800431312A patent/CN1956732B/zh not_active Expired - Fee Related
- 2004-08-27 DE DE602004009113T patent/DE602004009113T2/de not_active Expired - Lifetime
- 2004-08-27 UA UAA200612258A patent/UA82782C2/uk unknown
- 2004-08-27 HR HR20070574T patent/HRP20070574T3/xx unknown
- 2004-08-27 SI SI200430552T patent/SI1750765T1/sl unknown
- 2004-08-27 EP EP04816650A patent/EP1750765B1/fr not_active Expired - Lifetime
- 2004-08-27 PL PL04816650T patent/PL1750765T3/pl unknown
- 2004-08-27 DK DK04816650T patent/DK1750765T3/da active
- 2004-08-27 JP JP2007512723A patent/JP2007537242A/ja active Pending
- 2004-08-27 ES ES04816650T patent/ES2294577T3/es not_active Expired - Lifetime
- 2004-08-27 AT AT04816650T patent/ATE373488T1/de active
- 2004-08-27 WO PCT/IN2004/000266 patent/WO2005107809A2/fr not_active Ceased
- 2004-08-27 AP AP2006003807A patent/AP1994A/xx active
- 2004-08-27 GE GEAP20049749A patent/GEP20094805B/en unknown
- 2004-08-27 MX MXPA06012984A patent/MXPA06012984A/es active IP Right Grant
- 2004-08-27 KR KR1020067023513A patent/KR100854309B1/ko not_active Expired - Fee Related
2005
- 2005-05-11 SV SV2005002109A patent/SV2006002109A/es not_active Application Discontinuation
- 2005-05-11 PE PE2005000526A patent/PE20060353A1/es not_active Application Discontinuation
- 2005-05-11 MY MYPI20052107A patent/MY139187A/en unknown
- 2005-05-11 UY UY28893A patent/UY28893A1/es unknown
- 2005-05-11 AR ARP050101898A patent/AR048948A1/es not_active Application Discontinuation
- 2005-05-11 DO DO2005000085A patent/DOP2005000085A/es unknown
- 2005-05-12 SM SM200500011A patent/SM200500011B/it unknown
- 2005-05-12 HN HN2005000210A patent/HN2005000210A/es unknown
- 2005-05-12 PA PA20058633001A patent/PA8633001A1/es unknown
- 2005-05-12 JO JO200559A patent/JO2471B1/en active
- 2005-05-14 SA SA5260130A patent/SA05260130B1/ar unknown
2006
- 2006-10-24 ZA ZA200608843A patent/ZA200608843B/xx unknown
- 2006-10-25 IL IL178858A patent/IL178858A/en not_active IP Right Cessation
- 2006-10-26 IS IS8559A patent/IS8559A/is unknown
- 2006-10-30 TN TNP2006000349A patent/TNSN06349A1/en unknown
- 2006-10-30 EC EC2006006965A patent/ECSP066965A/es unknown
- 2006-11-10 CR CR8748A patent/CR8748A/es not_active Application Discontinuation
- 2006-11-10 NI NI200600270A patent/NI200600270A/es unknown
- 2006-11-23 MA MA29484A patent/MA28603B1/fr unknown
- 2006-12-12 NO NO20065725A patent/NO20065725L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI1750765T1 (sl)	2008-04-30
AU2004319259A1 (en)	2005-11-17
ZA200608843B (en)	2008-07-30
US7491721B2 (en)	2009-02-17
CR8748A (es)	2008-06-02
NO20065725L (no)	2006-12-12
PT1750765E (pt)	2007-12-31
CN1956732B (zh)	2010-04-28
MA28603B1 (fr)	2007-05-02
MXPA06012984A (es)	2007-04-23
SV2006002109A (es)	2006-04-18
DOP2005000085A (es)	2007-01-15
AR048948A1 (es)	2006-06-14
HK1098962A1 (en)	2007-08-03
KR20070007920A (ko)	2007-01-16
DK1750765T3 (da)	2008-01-28
CA2566440A1 (fr)	2005-11-17
WO2005107809A3 (fr)	2006-01-26
RS20060624A (sr)	2008-09-29
NI200600270A (es)	2007-12-11
ATE373488T1 (de)	2007-10-15
UY28893A1 (es)	2005-12-30
AP1994A (en)	2009-04-09
BRPI0418770A (pt)	2007-10-09
SM200500011A (it)	2005-11-16
KR100854309B1 (ko)	2008-08-26
TNSN06349A1 (en)	2008-02-22
MY139187A (en)	2009-08-28
US20050256128A1 (en)	2005-11-17
IL178858A (en)	2010-06-16
IS8559A (is)	2006-10-26
SM200500011B (it)	2005-11-16
SA05260130B1 (ar)	2008-05-04
JO2471B1 (en)	2009-01-20
JP2007537242A (ja)	2007-12-20
DE602004009113T2 (de)	2008-06-19
ECSP066965A (es)	2006-12-20
GEP20094805B (en)	2009-10-26
EP1750765B1 (fr)	2007-09-19
IL178858A0 (en)	2007-03-08
NZ550892A (en)	2009-12-24
AP2006003807A0 (en)	2006-12-31
ES2294577T3 (es)	2008-04-01
WO2005107809A2 (fr)	2005-11-17
EP1750765A2 (fr)	2007-02-14
PE20060353A1 (es)	2006-07-08
CN1956732A (zh)	2007-05-02
HN2005000210A (es)	2009-03-17
PL1750765T3 (pl)	2008-02-29
UA82782C2 (uk)	2008-05-12
DE602004009113D1 (de)	2007-10-31
CA2566440C (fr)	2009-08-04
EA200601952A1 (ru)	2007-02-27
WO2005107809A8 (fr)	2006-05-18
EA009694B1 (ru)	2008-02-28
PA8633001A1 (es)	2006-12-07

Publication	Publication Date	Title
AR025055A1 (es)	2002-11-06	Composiciones farmaceuticas
NO20043913L (no)	2004-11-16	Blandinger med modifisert frigjoring av i det minste en form av tramadol
MXPA05012248A (es)	2006-02-10	Fenil quinolinas y su uso como moduladores del receptor de estrogeno.
TR200200795T2 (tr)	2002-07-22	5-HT1B antagonistleri olarak piperazin türevleri
DK1897546T3 (da)	2011-01-17	Kombinerede sammensætninger omfattende (E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s]-3,5-dihydroxyhept-6-enoinsyre
CY1111698T1 (el)	2015-10-07	Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
PH12021550687A1 (en)	2022-02-14	Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
DE60230127D1 (de)	2009-01-15	Inhibitoren von integrin alpha-v-beta-6
ATE495187T1 (de)	2011-01-15	Dalda-analoge und ihre verwendung
CY1110906T1 (el)	2015-06-10	Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
DK1736158T3 (da)	2009-11-02	Anvendel af 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin samt de fysiologiske acceptable salte deraf
TW200624431A (en)	2006-07-16	Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
BR0313385A (pt)	2005-06-14	Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
DK1104289T3 (da)	2006-05-15	Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
UY27416A1 (es)	2003-03-31	Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana
GEP20094805B (en)	2009-10-26	Antimycobacterial pharmaceutical composition
BR0306923A (pt)	2004-12-28	Composição farmacêutica para regeneração de tecidos hepáticos para tratamento de cirrose do fìgado uso de 5-(2-pirazinil) -4-metil-1,2-ditiol-3-tiona
DK0777653T3 (da)	2001-10-08	Dihydropyridinderivater som bradykininantagonister
BRPI0409379A (pt)	2006-04-25	combinações de paroxetina e 1-(r)-(3-,5-bis-trifluormetil-fenil)-etil] metilamida do ácido (s)-(4-flúor-2-metil-fenil)-piperazina-1-carboxìlico para tratamento de depressão e/ou ansiedade
EA200702386A1 (ru)	2008-04-28	Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
MXPA05010135A (es)	2005-11-16	Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos.
TW200602329A (en)	2006-01-16	Novel diazine derivatives, their manufacture and use as pharmaceutical agents
TW200626591A (en)	2006-08-01	Amide derivatives, their manufacture and use as pharmaceutical agents
DE60310896D1 (de)	2007-02-15	PHARMAZEUTISCHE ZUBEREITUNGEN ENTHALTEND NANOPARTIKEL VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANSULPHONYL-PHENYL)-PYRAZOLOi1,5-BöPYRIDAZIN